TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biolin Scientific AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
12,674
|
10,611
|
10,456 |
Financial expenses |
43
|
42
|
24 |
Earnings before taxes |
2,149
|
1,867
|
1,474 |
EBITDA |
2,433
|
2,338
|
2,047 |
Total assets |
12,845
|
10,955
|
10,249 |
Current assets |
4,541
|
3,269
|
2,509 |
Current liabilities |
2,656
|
2,512
|
2,665 |
Equity capital |
10,097
|
8,369
|
7,509 |
- share capital |
2,396
|
2,389
|
2,599 |
Employees (average) |
24
|
21
|
23 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
78.6%
|
76.4%
|
73.3% |
Turnover per employee |
528
|
505
|
455 |
Profit as a percentage of turnover |
17.0%
|
17.6%
|
14.1% |
Return on assets (ROA) |
17.1%
|
17.4%
|
14.6% |
Current ratio |
171.0%
|
130.1%
|
94.1% |
Return on equity (ROE) |
21.3%
|
22.3%
|
19.6% |
Change turnover |
2,032
|
1,002
|
1,599 |
Change turnover % |
19%
|
10%
|
18% |
Chg. No. of employees |
3
|
-2
|
4 |
Chg. No. of employees % |
14%
|
-9%
|
21% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.